Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

36 results about "Retinal Neuron" patented technology

Scanning laser device and methods of use

In one aspect, the invention provides vision prosthesis systems. Exemplary vision prosthesis systems of the invention comprise a light energy generator operably connected to a wearable head piece comprising a device for directing light energy produced by the light energy generator onto a mammalian retina, wherein the light energy generator is tuned to emit light energy of sufficient power to modulate neural activity in the retina. In another aspect, the invention provides methods for irradiating neurons in the retina of the mammalian eye by directing light energy produced by a light energy generator onto a mammalian retina. The methods of the invention may be used to directly modulate the activity of retinal neurons or to introduce molecules into retinal cells.
Owner:UNIV OF WASHINGTON

Scanning laser device and methods of use

In one aspect, the invention provides vision prosthesis systems. Exemplary vision prosthesis systems of the invention comprise a light energy generator operably connected to a wearable head piece comprising a device for directing light energy produced by the light energy generator onto a mammalian retina, wherein the light energy generator is tuned to emit light energy of sufficient power to modulate neural activity in the retina. In another aspect, the invention provides methods for irradiating neurons in the retina of the mammalian eye by directing light energy produced by a light energy generator onto a mammalian retina. The methods of the invention may be used to directly modulate the activity of retinal neurons or to introduce molecules into retinal cells.
Owner:UNIV OF WASHINGTON

Restoration of visual responses by in vivo delivery of rhodopsin nucleic acids

Nucleic acid vectors encoding light-gated cation-selective membrane channels, in particular channelrhodopsin-2 (Chop2), converted inner retinal neurons to photosensitive cells in photoreceptor-degenerated retina in an animal model. Such treatment restored visual perception and various aspects of vision. A method of restoring light sensitivity to a retina of a subject suffering from vision loss due to photoreceptor degeneration, as in retinitis pigmentosa or macular degeneration, is provided. The method comprises delivering to the subject by intravitreal or subretinal injection, the above nucleic acid vector which comprises an open reading frame encoding a rhodopsin, to which is operatively linked a promoter and transcriptional regulatory sequences, so that the nucleic acid is expressed in inner retinal neurons. These cells, normally light-insensitive, are converted to a light-sensitive state and transmit visual information to the brain, compensating for the loss, and leading to restoration of various visual capabilities.
Owner:WAYNE STATE UNIV +1

Noninvasive Ultrasound-Based Retinal Stimulator: Ultrasonic Eye

A retinal stimulation and prosthetic device is provided that includes at least one ultrasonic transducer having a focused ultrasonic signal, where the focused ultrasonic signal includes an acoustic frequency, a spot size, a temporal pattern, a pulse duration and a power capable of stimulating retinal neurons when the at least one ultrasonic transducer is disposed proximal to an eye.
Owner:THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIV

Method and apparatus for visual neural stimulation

Existing epiretinal implants for the blind are designed to electrically stimulate large groups of surviving retinal neurons using a small number of electrodes with diameters of several hundred μm. To increase the spatial resolution of artificial sight, electrodes much smaller than those currently in use are desirable. In this study we stimulated and recorded ganglion cells in isolated pieces of rat, guinea pig, and monkey retina. We utilized micro-fabricated hexagonal arrays of 61 platinum disk electrodes with diameters between 6 and 25 μm, spaced 60 μm apart. Charge-balanced current pulses evoked one or two spikes at latencies as short as 0.2 ms, and typically only one or a few recorded ganglion cells were stimulated. Application of several synaptic blockers did not abolish the evoked responses, implying direct activation of ganglion cells. Threshold charge densities were typically below 0.1 mC / cm2 for a pulse duration of 100 μs, corresponding to charge thresholds of less than 100 pC. Stimulation remained effective after several hours and at high frequencies. To demonstrate that closely spaced electrodes can elicit independent ganglion cell responses, we utilized the multi-electrode array to stimulate several nearby ganglion cells simultaneously. From these data we conclude that electrical stimulation of mammalian retina with small-diameter electrode arrays is achievable and can provide high temporal and spatial precision at low charge densities. We review previous epiretinal stimulation studies and discuss our results in the context of 32 other publications, comparing threshold parameters and safety limits.
Owner:SALK INST FOR BIOLOGICAL STUDIES +1

Microelectronic stimulator array for stimulating nerve tissue

The retinal prosthesis test device is comprised of a thin wafer of glass made from nanochannel glass (NGC) with very small channels perpendicular to the plane of the wafer filled with an electrical conductor forming microwires. One surface of the glass is ground to a spherical shape consistent with the radius of curvature of the inside of the retina. The NGC is hybridized to a silicon de-multiplexer and a video image is serially input to a narrow, flexible micro-cable and read into a 2-D array of unit cells in a pixel-by-pixel manner which samples the analog video input and stores the value as a charge on a MOS capacitor. After all unit cells have been loaded with the pixel values for the current frame, a biphasic pulse is sent to each unit cell which modulates the pulse in proportion to the pixel value stored therein. Because the biphasic pulses flow in parallel to each unit cell from a global external connection, the adjacent retinal neurons are all stimulated simultaneously, analogous to image photons stimulating photoreceptors in a normal retina. A permanent retinal implant device uses a NGC array hybridized to a silicon chip, the image is simultaneously generated within each cell through a photon-to-electron conversion using a silicon photodiode. The photons propagate directly through into the backside of the device. Electrical power and any control signals are transmitted through an inductively driven coil or antenna on the chip. The device collects the charge in storage capacitors via the photon-to-electron conversion process, stimulates the neural tissue with biphasic pulses in proportion to the stored charges, and resets the storage capacitors to repeat the process.
Owner:THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY

Method and Apparatus for Visual Neural Stimulation

Existing epiretinal implants for the blind are designed to electrically stimulate large groups of surviving retinal neurons using a small number of electrodes with diameters of several hundred μm. To increase the spatial resolution of artificial sight, electrodes much smaller than those currently in use are desirable. In this study we stimulated and recorded ganglion cells in isolated pieces of rat, guinea pig, and monkey retina. We utilized micro-fabricated hexagonal arrays of 61 platinum disk electrodes with diameters between 6 and 25 μm, spaced 60 μm apart. Charge-balanced current pulses evoked one or two spikes at latencies as short as 0.2 ms, and typically only one or a few recorded ganglion cells were stimulated. Application of several synaptic blockers did not abolish the evoked responses, implying direct activation of ganglion cells. Threshold charge densities were typically below 0.1 mC / cm2 for a pulse duration of 100 μs, corresponding to charge thresholds of less than 100 pC. Stimulation remained effective after several hours and at high frequencies. To demonstrate that closely spaced electrodes can elicit independent ganglion cell responses, we utilized the multi-electrode array to stimulate several nearby ganglion cells simultaneously. From these data we conclude that electrical stimulation of mammalian retina with small-diameter electrode arrays is achievable and can provide high temporal and spatial precision at low charge densities. We review previous epiretinal stimulation studies and discuss our results in the context of 32 other publications, comparing threshold parameters and safety limits.
Owner:SECOND SIGHT MEDICAL PRODS +1

Methods and compositions for the treatment of glaucoma and other retinal diseases

Disclosed herein are methods and compositions for treating glaucoma and other disorders related to degeneration of retinal neuronal cells, by treating a subject with a composition capable of inducing or increasing the expression of the 70 kD family of heat shock proteins (HSP70) in retinal neurons. Preferred embodiments include geranylgeranylacetone and / or gene therapy applications.
Owner:RGT UNIV OF CALIFORNIA

Methods and compositions for gene delivery to on bipolar cells

Disclosed are capsid-modified rAAV expression vectors, as well as infectious virions, compositions, and pharmaceutical formulations that include them. Also disclosed are methods of preparing and using novel capsid-protein-mutated rAAV vector constructs in a variety of diagnostic and therapeutic applications including, inter alia, as delivery agents for diagnosis, treatment, or amelioration of one or more diseases, disorders, or dysfunctions of the mammalian eye. Also disclosed are methods for intravitreal delivery of therapeutic gene constructs to retinal neuron cells, and specifically to ON bipolar cells, of the mammalian eye, as well as use of the disclosed compositions in the manufacture of medicaments for a variety of in vitro and / or in vivo applications including the treatment of retinitis pigmentosa, melanoma-associated retinopathy, and congenital stationary night blindness.
Owner:THE UNIV OF BRITISH COLUMBIA +1

An image enhancement method in a dark light environment

The invention discloses an image enhancement method in a dark light environment and belongs to the field of image processing. The problems of distorted representation result, blurred image contour andlow color saturation after enhancement seriously exist can be solved; The method comprises the following steps: extracting a brightness component V in an HSV in a dark light image, carrying out logarithmic transformation of global brightness, and carrying out overall brightness improvement on a low-illumination area in the dark light image; Obtaining neighborhood average brightness of pixel points in the current dark light image by using bilateral filtering under a receptive field three-Gaussian model of the retinal neurons; A function of extracting a local bright part from an image background is realized by utilizing top and bottom cap transformation processing, and then light and shade extraction and noise reduction are carried out on the image by utilizing top and bottom cap transformation; According to the method, the enhanced details of the dark-light color image can be well represented, the problem of non-uniform illumination distribution is solved, the overall contrast of the image is improved, the detail contour of the image is clear, and the color saturation is high.
Owner:HARBIN UNIV OF SCI & TECH

Image color constancy method under multi-light-source environment

The invention discloses an image color constancy method under a multi-light-source environment. The invention puts forward a multi-light-source color constancy method based on a retina physiological mechanism, simulates the light and dark adaption capability of vision and the characteristics of a retinal neuron reception field, and establishes a model based on ON type and OFF type reception fields on the basis of light and dark area division, the model can favorably estimate the position and the color of a light source, and parameters can be regulated to adapt to different scene images. The method has the characteristics of few parameters, simpleness in calculation, high speed, good effect and the like, can carry out real-time processing, and is very suitable to be built in the preprocessing front end of physical equipment to estimate a scene light source color in the image.
Owner:UNIV OF ELECTRONICS SCI & TECH OF CHINA

Inhibition of reactive oxygen species and protection of mammalian cells

Methods and compositions useful for neuronal protection in retinal cells in vitro and the protection of mammalian cells from reactive oxygen species in vivo are provided. Ultrafine nano-size cerium oxide particles, less than 10 nanometers in diameter, have been provided to decrease reactive oxygen species (ROS) in retina tissue that generates large amounts of ROS. These reactive oxygen species (ROS) are involved in light-induced retina degeneration and age-related macular degeneration (AMD). Cerium oxide nanoparticles have been used to promote the lifespan of retinal neurons and protect the neurons from apoptosis induced by hydrogen peroxide in vitro and in vivo. The neuronal protection in retinal cells is achieved by decreasing generation of intracellular reactive oxygen species (ROS). Thus, cerium oxide particles are used to promote the longevity of retinal neurons in vitro and mammalian cells in vivo.
Owner:UNIV OF CENT FLORIDA RES FOUND INC +1

Method used for inducing differentiation of human multipotential stem cells into retinal progenitor cells

The invention belongs to the field of biomedicine, and specifically relates to a method used for inducing differentiation of human multipotential stem cells into retinal progenitor cells. According to the method, human embryonic stem cells or human induced multipotential stem cells are induced in a medium containing N2, and then are delivered into a retina induction medium containing neural basis culture medium, knockout serum replacement and nicotinamide so as to obtain the retinal progenitor cells. The method is capable of increasing differentiation rate of human multipotential stem cells into retinal progenitor cells; and the retinal progenitor cells obtained via differentiation can be used for transplantation therapy of irreversible degenerative diseases of retinal neurons, such as age-related macular degeneration and retinitis pigmentosa, and also can be used for iPS cells sourced from patients as cell models in drug screening and gene interference experiments. Compared with existing technology, small molecule compounds used in the method are less, so that influences caused by non-anthropogenic factors are avoided effectively, and yield of obtained optic cup-like cells is obviously higher than that of existing induced differentiation methods.
Owner:FUDAN UNIV

Visual pathway multi-receptive-field directional association-based profile detection method

ActiveCN106127740AIn line with the spatial information processing mechanismEasy accessImage enhancementImage analysisPattern recognitionRetinal Neuron
The invention discloses a visual pathway multi-receptive-field directional association-based profile detection method. According to the method, classic receptive field characteristics of retinal neurons and non classic receptive field characteristics of LGN (Lateral Geniculate Nucleus) cells in a visual pathway are simulated from spatial scale characteristics of receptive fields of all levels and mutual associativity of receptive fields of the same level in the visual pathway, and rectangular receptive fields of the LGN cells are associated directionally for simulating direction selection characteristics of simple cells of V1 (primary visual cortex). According to the visual pathway multi-receptive-field directional association-based profile detection method proposed by the invention, an important role of visual characteristics in profile detection is brought into full play.
Owner:杭州感想信息技术有限公司

A light-stimulated retinal prosthesis repair device and repair method

The invention relates to a light stimulation based retinal prosthesis repairing method and device. The method is performed by directly carrying out light stimulation on retinal neurons to help the blind to repair visual sense. The device is composed of image collecting and image processing subsystems, an LED (light-emitting diode) array and an LED control signal generator. The method can effectively stimulate retinal neurons and restore visual perception of patients with ablepsy, and has important social significance for improving the life quality of the blind.
Owner:CHONGQING UNIV

Kit for treating retinal disease

The invention discloses a kit for treating a retinal disease. The kit and a medicament for treating the retinal disease, which are disclosed by the invention, are characterized in that the effective component is adenovirus capable of carrying out overexpression on ribonucleic acid binding protein Lin28B. Injection for a plurality of times is not required when the retinal disease is treated by adopting the kit disclosed by the invention, retinal endogenous stem cells can be activated to the maximal extent by retina inferior vena injection, and the endogenous stem cells are promoted to be differentiated into retinal neurons.
Owner:THE FIRST AFFILIATED HOSPITAL OF THIRD MILITARY MEDICAL UNIVERSITY OF PLA

Retinal prostheses

PendingUS20210121685A1Without sacrificing fill factorImprove eyesightTransistorHead electrodesRetinal ProsthesisField effect
Optoelectronic retinal prostheses transduce light into electrical current for neural stimulation. A novel optoelectronic pixel architecture is presented comprising a vertically integrated photo junction field-effect-transistor (Photo-JFET) and neural stimulating electrode. Experimental measurements demonstrate that optically addressed Photo-JFET pixels utilize phototransistive gain to produce a broad range of neural stimulation current and can effectively stimulate retinal neurons in vitro. The compact nature of the Photo-JFET pixel can enable high resolution retinal prostheses with a theoretical visual acuity ˜20 / 60 to help restore vision in patients with degenerative retinal diseases.
Owner:NANOVISION BIOSCIENCES INC

Method and Apparatus for Visual Neural Stimulation

Existing epiretinal implants for the blind are designed to electrically stimulate large groups of surviving retinal neurons using a small number of electrodes with diameters of several hundred μm. To increase the spatial resolution of artificial sight, electrodes much smaller than those currently in use are desirable. In this study we stimulated and recorded ganglion cells in isolated pieces of rat, guinea pig, and monkey retina. We utilized micro-fabricated hexagonal arrays of 61 platinum disk electrodes with diameters between 6 and 25 μm, spaced 60 μm apart. Charge-balanced current pulses evoked one or two spikes at latencies as short as 0.2 ms, and typically only one or a few recorded ganglion cells were stimulated. Application of several synaptic blockers did not abolish the evoked responses, implying direct activation of ganglion cells. Threshold charge densities were typically below 0.1 mC / cm2 for a pulse duration of 100 μs, corresponding to charge thresholds of less than 100 pC. Stimulation remained effective after several hours and at high frequencies. To demonstrate that closely spaced electrodes can elicit independent ganglion cell responses, we utilized the multi-electrode array to stimulate several nearby ganglion cells simultaneously. From these data we conclude that electrical stimulation of mammalian retina with small-diameter electrode arrays is achievable and can provide high temporal and spatial precision at low charge densities. We review previous epiretinal stimulation studies and discuss our results in the context of 32 other publications, comparing threshold parameters and safety limits.
Owner:SALK INST FOR BIOLOGICAL STUDIES +1

Compositions and methods for use of cannabinoids for neuroprotection

Provided herein are methods and compositions for neuroprotection. The neuroprotective composition can be or include cannabinol or a derivative thereof. The neuroprotective composition can be used in the treatment of a neurodegenerative disease. The neuroprotective composition can be used to protect retinal neurons from degeneration in a subject in need thereof, such as for treatment of glaucoma.
Owner:因美制药公司

Method for promoting in-vitro amplification of RPCs (retinal progenitor cells) of mouse by inhibiting microRNA (micro ribonucleic acid)

The invention discloses a method for promoting in-vitro amplification of RPCs (retinal progenitor cells) of a mouse by inhibiting microRNA (micro ribonucleic acid). MicroRNA miR-449a-5p is a non-codedsingle-stranded RNA molecule with length of 22 nucleotides, and the coded DNA sequence of the molecule is located on chromosome 13 of the mouse. The RPCs are cells with self-renewal capacity as wellas potential of being differentiated into retinal neurons and neuroglia. By means of synthesis of an antisense strand of miR-449a-5p, interference to level of endogenous miR-449a-5p is realized according to the principle of complementary pairing of basic groups, and in-vitro amplification of the RPCs can be effectively performed. The RPCs are development sources of photoreceptor cells in mature neural retina, so that the effective in-vitro amplification method can promote cell therapy based on stem / precursor cell transplantation.
Owner:FOURTH MILITARY MEDICAL UNIVERSITY

Application of 7,8-dihydroxyflavone (DHF) to preparation of drug for treating retinal degenerative diseases

The invention belongs to the pharmaceutical field and relates to an application of 7,8-dihydroxyflavone (DHF) to preparation of a drug for treating retinal degenerative diseases. Through adult SD rat optic nerve contusion model experiments, the results show that 7,8-DHF can achieve the effects of reducing apoptosis of retinal ganglion cells and increasing the survival rate and has obvious protective effects on injured retinal neurons. 7,8-DHF is used for further treating the retinal degenerative diseases by protecting the injured retinal neurons, wherein the retinal degenerative diseases include glaucoma, macular degeneration, retinitis pigmentosa, ischemic optic neuropathy and traumatic optic nerve contusion. The invention also provides a novel small molecular drug preparation with 7,8-DHF as the main active ingredient. Obvious protective effects can be generated for the injured retinal neurons by locally delivering the drug to the vitreous cavities of eyes.
Owner:EYE & ENT HOSPITAL SHANGHAI MEDICAL SCHOOL FUDAN UNIV

Agent for protection of retinal neurons

This invention relates to an agent for the protection of retinal neurons which comprises, as an effective ingredient, sulfamate derivative having the following formula: and to a method for the protection of retinal neurons by using said sulfamate derivative.
Owner:ORTHO MCNEIL PHARM INC

A method for image color constancy in multi-light source environment

The invention discloses an image color constant method in a multi-light source environment. The invention proposes a multi-light source color constant method based on the physiological mechanism of the retina, which simulates the visual light-dark adaptation ability and the characteristics of the retinal neuron receptive field, and establishes the following method: A model based on ON and OFF receptive fields based on the division of bright and dark areas, this model can well estimate the position and color of the light source, and can adjust parameters to adapt to different scene images. The method of the present invention has the characteristics of few parameters, simple calculation, fast speed, good effect, and real-time processing, and is very suitable for being built in the front end of physical equipment preprocessing to estimate the color of the scene light source in the image.
Owner:UNIV OF ELECTRONICS SCI & TECH OF CHINA

A method to promote in vitro expansion of mouse retinal precursor cells by inhibiting microRNAs

The invention discloses a method for promoting the in vitro expansion of mouse retinal precursor cells by inhibiting microribonucleic acid. MicroRNA miR-449a-5p is a non-coding single-stranded RNA molecule of 22 nucleotides in length, and its coding DNA sequence is located on mouse chromosome 13. Retinal precursor cells are a class of cells with self-renewal ability and the potential to differentiate into retinal neurons and glial cells. By synthesizing the antisense strand of miR-449a-5p and using the principle of base pairing to interfere with the level of endogenous miR-449a-5p, it can effectively promote the expansion of retinal precursor cells in vitro. Since retinal precursor cells are the developmental source of photoreceptor cells in the mature neural retina, their efficient in vitro expansion method could facilitate cell therapy based on stem / precursor cell transplantation.
Owner:FOURTH MILITARY MEDICAL UNIVERSITY

Retinal neuron coding method based on convolutional neural network

The invention discloses a retinal neuron coding method based on a convolutional neural network. The method comprises the following steps: S1, obtaining ganglion cell stimulation data and correspondingresponse data; S2, constructing a CNN model for training, including the following steps: S21, inputting ganglion cell stimulation data into a first convolution layer; S22, inputting the output of thefirst convolution layer into a second convolution layer; S23, inputting the output of the second convolution layer into a full connection layer; S24, comparing the output with the response data, andoptimizing the output of the CNN model; and S3, predicting response data of ganglion cells through the trained CNN model; the CNN model is selected because the CNN model has strong nonlinear computingpower, through experiments, when the convolution layer of the CNN model is 2, the effect is the best, only one output neuron exists in a full connection layer, and information is corrected through anactivation function.
Owner:ZHEJIANG LAB
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products